Publications



[Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients].
Bull Cancer 2017 Mar 13;104(3):208-212. Epub 2016 Dec 13.
Centre Oscar-Lambret, département d'oncologie médicale, 3, rue Combemale, 59020 Lille cedex, France; CHRU de Lille, SIRIC OncoLille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France. Electronic address:

Selection of ultimately ill cancer patients able to fulfill a questionnaire: Identification of inherent biases.
Bull Cancer 2015 Sep 30;102(9):730-6. Epub 2015 Jul 30.
University Lille 3, URECA EA 1059 (Research Unit: Cognitive and Affective Sciences), UFR de psychologie, rue du Barreau, BP 60149, 59653 Villeneuve d'Ascq cedex, France; University Lille 2, EA 264 (Resarch Unit: Epidemiology and Care Quality) and SIRIC ONCoLille, Platform 4, place de Verdun, 59045 Lille cedex, France. Electronic address:


Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis.
Eur J Cancer 2015 Jan 9;51(2):202-9. Epub 2014 Dec 9.
Medical Oncology Department, Centre Oscar Lambret, 3 rue Combemale, 59020 Lille cedex, France; Clinical Resarch and Methodological Platform, SIRIC OncoLille, Lille, France. Electronic address:

What is an active regimen in carcinoma of unknown primary sites? Analysis of correlation between activity endpoints reported in phase II trials. Correlation of activity endpoints in phase II trials.
Bull Cancer 2014 Apr;101(4):E19-24
Lille Nord-de-France University, Unit Research (EA 2694) Medical School, 1, place de verdun, 59000 Lille, France, Centre Oscar-Lambret, Methodology and Biostatistics Unit, 3, rue Frédéric-Combemale, 59020 Lille cedex, France.

OF